5 Biomedical Stocks That Are Expected To Surge

Geron recently formed an agreement with Johnson & Johnson’s Janssen Biotech (JNJ). The agreement will provide Geron with a strong partner and funds. The new license could allow the company to receive up to an additional $900 million on the achievement of development, which bodes well for shareholders. Along with this development, Geron has an astronomical projected sales growth of 247.83% for the next year. In essence, it sounds like it is the right time to purchases shares of Geron Corporation, a stock that currently has a Zacks Rank #2 (Buy).

3. Kadmon Holdings, Inc. (KDMN - Free Report)

Kadmon Holdings is a biopharmaceutical company engaged in the development and commercialization of small molecules to address major diseases. The company demolished their projected earnings last quarter by 22%, andKadmon is anticipated to explode in the near future.

Additionally, Kadmon’s projected EPS growth of 77.89% and current Cash Flow growth of 130.95% towers over the industry averages of 5.52% and 13.76%, respectively. Kadmon received an “A” grade in Growth and “B” grade in Momentum, which means that the stock is projected to increase while the company continues to develop. The company’s current share price is close to its past 52 week low; however, its share price has skyrocketed in the past week by 20.44%. Basically, now might be the perfect time to invest in Kadmon Holdings, which recently scored a Zacks Rank #2 (Buy).

4. Anavex Life Sciences Corporation (AVXL - Free Report)

Anavex Life Sciences is an emerging biopharmaceutical company engaged in the discovery and development of drugs for the treatment of cancer and neurological diseases. Even though this company operates in a rather unpredictable industry, Anavex sports a beta rating of 0.64. Anavex also received a “B” grade for Momentum on our Style Scores system which means its share prices have already been rising considerably.

View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any ...

more
How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Craig Newman 2 years ago Member's comment

Not any time soon! They have to wait for the Healthcare Bill to pass before traders spend another dime!